CorMedix

CRMD · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 23 days ago

Total Revenue

$129M

Previous year: $31.2M

Previous year: $15.3M

+404.2%

R&D Expenses

$8.6M

Previous year: $1.73M

+398.0%

S&M Expenses

$16M

Previous year: $8.26M

Previous year: $40.8M

Loading...

CorMedix

Unlock previous datapoints

Upgrade

CorMedix

Unlock previous datapoints

Upgrade

CorMedix Revenue by Segment

Revenue by Segment

DefenCath Revenue

CapyFin.com

Melinta Portfolio Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$530M

P/E Ratio

3.43

Sector

N/A

Industry

N/A

52-Week High

$16.5

52-Week Low

$5.85

Adjusted EBITDA

$77.2M

R&D Expenses

$8.6M

S&M Expenses

$16M

G&A Expenses

$23.6M

Total Operating Expenses

$48.2M

Products

Get in Touch

Resources

CorMedix

CorMedix

CorMedix

CorMedix Revenue by Segment

Revenue by Segment

DefenCath Revenue

Melinta Portfolio Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics